Cardiac gating finds use with X-SPECT

Article

Gamma Medica has begun marketing a cardiac gating subsystem for its preclinical imaging system. X-SPECT, the company's second-generation MicroSPECT system, is used by medical researchers and drug companies to visualize molecular markers in animal

Gamma Medica has begun marketing a cardiac gating subsystem for its preclinical imaging system. X-SPECT, the company's second-generation MicroSPECT system, is used by medical researchers and drug companies to visualize molecular markers in animal subjects. The gating subsystem freezes movement of the heart to allow more accurate in vivo cardiac imaging.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.